Condition: Myxoid Liposarcoma · Sponsor: The Netherlands Cancer Institute
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
This description comes directly from the study's public registry record.
Rick Haas, MD/PhD · +31 20 512 9111 · r.haas@nki.nl
Jules Lansu, MD/PhD · +31 20 512 9111 · j.lansu@nki.nl
Always discuss trial participation with your own doctor first.
| The Netherlands Cancer Institute | Amsterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04699292